Drugplain

FLUZONE TIV SH 2026 15 ug/.5mL

INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) · INJECTION, SUSPENSION · Sanofi Vaccines US Inc.

No Recall History
Plain English

FLUZONE TIV SH 2026 is a injection, suspension containing influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) at 15 ug/.5mL, taken intramuscular. Manufactured by Sanofi Vaccines US Inc..

Key Facts

Brand Name
FLUZONE TIV SH 2026
Generic Name
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)
NDC Code (Product)
49281-626
Manufacturer
Sanofi Vaccines US Inc.
Strength
15 ug/.5mL
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Marketing Status
Application #
BLA103914
Marketing Start
02/20/2026

Recall History

No Recall History

Frequently Asked Questions

What is FLUZONE TIV SH 2026 used for?

FLUZONE TIV SH 2026 contains INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED). It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.

Is FLUZONE TIV SH 2026 a controlled substance?

FLUZONE TIV SH 2026 is not classified as a controlled substance by the DEA.

What is the generic name for FLUZONE TIV SH 2026?

The generic name for FLUZONE TIV SH 2026 is INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED). There are 1 other brand versions of INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED).

What is the NDC code for FLUZONE TIV SH 2026 15 ug/.5mL?

The NDC (National Drug Code) for FLUZONE TIV SH 2026 15 ug/.5mL is 49281-626, listed by Sanofi Vaccines US Inc..

Product NDC

49281-626

Package NDC

49281-626-50

Other FLUZONE TIV SH 2026 Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)